Nearly 4,000 Participants Expected at JDRF Nevada Chapter’s Walk to Cure Diabetes

Nearly 4,000 Participants Expected at JDRF Nevada Chapter's Walk to Cure Diabetes
Nearly 4,000 walkers who represent families, local businesses, schools, and other community organizations touched in some way by type 1 diabetes (T1D) are expected at the JDRF Nevada Chapter’s annual Walk to Cure Diabetes, on Saturday, October 25, 2014 at UNLV

The chapter has set a $542,000 fundraising goal this year which will help fund research toward preventing, better treating, and curing type 1 diabetes (T1D) and its complications.

“There have been tremendous strides made in the technology and treatment available to those with type 1 diabetes in the last several years,” said Colleen Saca, Executive Director of the Nevada Chapter of JDRF. “This walk and those held across the nation allow us to continue funding the important research which is getting us closer to a cure.”

JDRF Walks are held in more than 200 cities worldwide. Nearly 900,000 people nationally walked last year and raised $86 million for research toward curing, treating, and preventing T1D and its complications.

Participants can sign up for the walk as an individual, create a team, join an existing team, or donate to someone already registered to walk by going to www.lv.jdrf.org. On-site registration for the walk begins at 9 a.m. on October 25, 2014 at UNLV’s North Field. The walk begins at 10 a.m. The 5K route will wind through the UNLV campus with several stations providing water and snacks.

JDRF Statistics:

  • 85 percent of those living withh type 1 diabetes are adults, most diagnosed as children or teenagers.
  • Type 1 diabetes is an autoimmunne disease that cannot be controlled through diet and/or exercise.
  • Insulin is not a cure; it is liife support for type 1 diabetics.
  • JDRF’s Advocacy efforts have raaised $1.9 billion so far for type 1 diabetes research.

To sign up for the walk or to make a donation, go to the website www.lv.jdrf.org or call &02-732-4795 for more information.

Comments are closed.